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ABSTRACT 
Introduction  Veterans are three times more likely to develop chronic obstructive pulmonary 
disease (COPD) than the general population.  This is likely due to increased use of tobacco and 
exposure to environmental risk factors.  Nutritional intake has been linked to COPD, and veterans 
report unique barriers to improving their eating habits.   
Purpose  The primary outcome of this study was to examine the relationship between antioxidant 
and anti-inflammatory nutrient intake and  lung function in veterans with COPD.  It was 
hypothesized that a higher intake of lutein + zeaxanthin, ß-cryptoxanthin, lycopene, retinol, ɑ-
carotene, ß-carotene, vitamin C, vitamin D, ɑ-tocopherol, omega-3, zinc and selenium would 
have a positive association on lung function in veterans with this disease.  It was further 
hypothesized that intakes of ɣ-tocopherol and omega-6 would have an inverse association with 
lung function.     
Methods  A total of 42 veterans participated in this prospective cohort study.  All participants 
filled out a food frequency questionnaire (FFQ) and lung function data were also gathered.  A 
micronutrient adequacy score was calculated from the results of the FFQ based on 2/3 
recommended dietary allowance (RDA).  Veteran’s smoking status and use of nutritional 
supplements was also included in the data analysis.  Significant findings were adjusted for 
possible confounders of age and smoking.  
Results  Participants had a very low intake of omega-3 as only 21% of veterans met the AI (1.6g 
for men) with a mean consumption of 0.3g.  Participants also consumed less of the anti-
inflammatory nutrient ɑ-tocopherol (mean intake of 8mg) compared to the pro-inflammatory 
nutrient ɣ-tocopherol (mean intake of 11mg).  Thirty participants (71%) had a micronutrient 
adequacy score of 4 out of 7.  However, when the nutrient consumption was evaluated separately, 
a low percentage of participants met the recommended intake for vitamin D (19%), ɑ-tocopherol 
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(5%), omega-3 (21% of males, 0% of females), zinc (25% of males, 0% of females) and selenium 
(0%).  Veterans had the highest consumption of retinol activity equivalents (RAEs) and vitamin 
C.  After adjusting for confounders, no significant relationship was found between nutrient intake 
and lung function.   
Conclusion  From the results of this study, it cannot be concluded that there is an association 
between the intakes of antioxidant and anti-inflammatory nutrients with lung function.  However, 
there are conflicting results in the literature and more research is needed in this area.   
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INTRODUCTION 
Veterans are three times more likely to develop COPD than the general population. 
Higher tobacco usage is found in military personnel compared to civilians, and 75% of COPD 
cases are tied to smoking.   Not only are veterans more likely to smoke, but they are also more 
exposed to environmental factors including dust from sand, smoke, or aerosolized metals and 
chemicals
1
.    
Nutrition and diet can affect the development of several chronic diseases.  In most recent 
years, lung diseases have become more of a concern including COPD
2
.
   
COPD is a major cause 
of morbidity and mortality worldwide and is the third leading cause of death in the United States.   
The prevalence of COPD is 3-4% in the United States and 10% worldwide
3, 4
.  The increase in 
prevalence has caused a rising concern within our healthcare system.    
 The increased concern of lung diseases has made maintaining or improving lung function 
a priority.  Many lung diseases, including COPD, involve oxidative stress and inflammation.  
Therefore researching nutrients with antioxidant and anti-inflammatory properties may be useful.  
These nutrients can be observed for prevention or treatments of lung diseases including COPD
2
.
 
    
Research looking at diet and COPD in veterans is unfortunately lacking.  This is an important 
area as research studies have shown there is an association between antioxidant and anti-
inflammatory nutrients with lung function in the general population.  Studies have also shown 
that veterans utilize health care more than civilians
5
.  They also have documented barriers, such 
as post-traumatic stress disorder, that impair their ability to improve their eating habits
6, 7
.       
The purpose of this study is to determine if there is an association between intakes of 
antioxidant and anti-inflammatory nutrients with lung function in veterans with COPD.  A 
micronutrient adequacy score was also created and analyzed to help identify the effects of diets 
higher in antioxidants and anti-inflammatory nutrients.  The effects of smoking status and 
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supplementation of these nutrients were analyzed.   It was hypothesized that a higher intake of 
lutein + zeaxanthin, ß-cryptoxanthin, lycopene, retinol, ɑ-carotene, ß-carotene, vitamin C, vitamin 
D, ɑ-tocopherol, omega-3, zinc and selenium would have a positive association on lung function 
in subjects with COPD.  It was further hypothesized that intakes of ɣ-tocopherol and omega-6 
would have an inverse association with lung function.   
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REVIEW OF THE LITERATURE 
COPD Overview 
            COPD is characterized by slow, progressive obstruction of the airways. COPD consists of 
two categories which are emphysema and chronic bronchitis.  Emphysema is characterized by 
abnormal, permanent enlargement, and destruction of the fragile walls and elastic fibers of the 
alveoli.  During exhalation, small airways collapse which impairs airflow out of the lungs
8, 9
.   
Chronic bronchitis usually involves a productive cough with inflammation of the bronchi and 
other lung changes.  The lungs produce more mucus which further blocks the narrowed tubes
10
.
 
   
Oxidative Stress and Inflammatory Mechanisms of COPD 
Oxidative stress is the production of free radicals and the body’s inability to counteract 
the harmful impact.  There is an oxidant-antioxidant imbalance in favor of oxidants, which can 
cause damage by free radicals to lung tissue.  Glutathione, a vital intra- and extracellular 
protective antioxidant, works against oxidative stress, which plays a key role in the control of 
pro-inflammatory processes in the lungs
11
.
 
  In a study by Ochs-Balcom et al. glutathione was 
observed as an oxidative stress biomarker.  Data was gathered in western New York State 
including 2,346 participants from 1995 to 2000.  A higher concentration of glutathione was found 
to increase an individual’s forced expiratory volume in one second (FEV1) (mean=93.4 FEV1); 
95% CI 91.6-95.3  p-trend <0.04)
12
.  
          The chronic inflammatory process in COPD is characterized by infiltration of the airways 
by neutrophils, macrophages, and CD8+ T cells.  Such features of inflammation in COPD are 
likely driven by various cellular pathways, including pro-inflammatory cytokines and mediators 
of oxidative stress released locally or systemically.  More than airway inflammation, a systemic 
inflammation has also been observed in COPD, with the detection of increased levels of 
10 
 
cytokines and inflammatory mediators, particularly from the endothelium, that can cause lung and 
airway injuries
4, 13
.   
               The early decline in lung function in COPD is correlated with inflammatory changes in 
the peripheral airways.  Inflammation leads to consistent and repetitive injuries to the peripheral 
airways caused by cigarette smoking which affects lung repair mechanisms
14
.
 
  Inflammatory 
changes such as airway edema and mucus hypersecretion also contribute to airway narrowing in 
COPD.  Inflammation of the submucosal glands and hyperplasia of goblet cells may contribute to 
symptoms, such as chronic sputum production. Fibrosis of airways plays the largest role in 
inflammation of the air passages. Bronchiolar abnormalities contribute more to mild-moderate 
chronic airflow limitation
15
.
 
    
COPD Diagnosis and GOLD Criterion 
 COPD requires close management as it progresses through its four stages.  The GOLD 
classification is the main method physicians use to describe the severity of COPD.  GOLD stands 
for Global Initiative for Chronic Obstructive Lung Disease.  This staging system was created 
between the National Institutes of Health and the World Health Organization.  FEV1/forced 
volume capacity (FVC) and FEV1 are used in conjunction to diagnose COPD and its severity
16, 17
.   
Individuals with COPD take longer to exhale air from their lungs which can be diagnosed by a 
FEV1/FVC of <70%.  The GOLD criterion is used to describe the severity of the airflow.  As the 
severity of COPD progresses FEV1 declines. A summarization of the GOLD criteria can be seen 
in Table 1.   
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Table 1:  COPD Severity by GOLD Criterion 
COPD Stage FEV1% predicted Post bronchodilator  
FEV1/FVC 
I.  Mild FEV1>80%    <0.7 
II.  Moderate 50% < FEV1 < 80%   <0.7 
III.  Severe 30% < FEV1 < 50%   <0.7 
IV.  Very Severe <30% FEV1   <0.7 
 
            There are a few factors that increase a patient’s risk of COPD.  Tobacco smoking or 
continual contact with second-hand smoke is the primary causative factor
14
.  Smoking decreases 
glutathione and also causes a fall in the plasma antioxidant capacity, a global measure of systemic 
oxidative stress
11
.   Environmental air pollution and genetic susceptibility are other possible 
causes
14
.
   
Age is also a factor and COPD develops slowly over the years and most individuals are 
at least 35 to 40 years old when symptoms begin
10
.
  
There are several symptoms that someone 
with COPD can experience which makes it difficult to diagnose.  Some of the most common are 
cough, dyspnea, and fatigue
18
.  
 COPD is commonly misdiagnosed as asthma or shortness of breath.  However, there are 
tests that can be completed in order to make an accurate diagnosis.  Some of the most frequently 
used are pulmonary function tests, but chest x-rays and CT scans can also be used.  An arterial 
blood gas analysis can measure how well lungs bring oxygen into the blood and remove carbon 
dioxide
8
.   Pulse oximetry can be used to measure oxygen saturation of the arterial blood.  The 
pulse oximeter uses light waves to measure oxygen saturation which normally is 95 to 99 
percent
11
.     
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Lung Function Tests 
Various tests are used to diagnose or monitor the status of lung disease.  Most are 
designed to measure the ability of the respiratory system to exchange oxygen and carbon dioxide.  
The major function of the pulmonary system is gas exchange.  Spirometry is what is used to 
measure lung function.  A participant breathes into a spirometer which gives information on lung 
volume and the rate at which air can be inhaled and exhaled
19
.
   
FVC is the volume delivered 
during an expiration made as forcefully and completely as possible, starting at full inspiration. 
FEV1 is the volume delivered in the first second of the FVC maneuver
17
.  
 
Interventions 
            There are many ways to improve symptoms and keep the disease from progressing.  
However, even though there are interventions there is still no cure.  For earlier stages of COPD, 
inhalers and steroids can help.  Inhalers, also known as bronchodilators, help open the airways 
while steroids help reduce lung inflammation.  Anti-inflammatory drugs can also be used to 
reduce swelling in the airways.   
            COPD exacerbations likely need a trip to the emergency room or a hospital stay.  In the 
hospital, patients still receive steroids, bronchodilators through a nebulizer, oxygen, or assistance 
breathing from a machine.  Some of these machines include bi-level positive airway pressure 
(BiPAP) or an endotracheal tube.  Surgery might also be an option for some people with severe 
emphysema.  This includes lung volume reduction surgery, in which small damaged lung tissue is 
removed, or some require a lung transplant
20
.     
Nutritional Intake of Veterans  
Eber et al. conducted a study to compare the health status between deployed and non-
deployed veterans in the same time frame.  This study involved 20, 563 veterans who were 
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surveyed periodically over a ten year period.  Veterans filled out a survey including questions 
regarding health status, deployment related exposures, and other relative questions.  Medical 
records were compiled to validate the questions from the survey such as reason for a doctor visit 
or overnight hospital stay within the past year.  Of the conditions mentioned in the survey, 89.3% 
of veterans had a confirmed medical condition that needed attention in the past year.  It was 
discovered that veterans were 29% more likely to develop a respiratory disease, such as asthma, 
bronchitis, or sinusitis compared to non-deployed veterans.  Deployed veterans also tend to utilize 
health care more often than civilians likely due to their higher susceptibility of chronic lung 
diseases, like COPD, and other medical conditions due to the increased exposure to 
environmental risk factors and increased rate of tobacco consumption.  
 
 Nosova et al reviewed the nutrient intake of 88 veterans with peripheral arterial disease.  
A validated questionnaire was used to estimate the subject’s average intake of nutrients from a 
variety of foods.  The values collected were then compared to guidelines set for the general 
population from the American Heart Association.  It was found that 59% of veterans consumed 
the daily recommended amount of omega-3 for people diagnosed with cardiovascular disease.  Of 
these participants, 28% reported taking an omega-3 supplement daily.  Veterans were also found 
to have a higher intake of cholesterol, sodium, and total fat.  Unfortunately, they were found to 
have an inadequate intake in magnesium, calcium, and soluble fiber.  It was concluded that 
veterans had a poor nutritional intake when compared to recommended guidelines for the general 
American population
6
.
  
   
 Another study looked at dietary intake in veterans with post-traumatic stress disorder 
(PTSD) compared to those without a mental health disorder.  Many veterans in the overall sample 
reported poor dietary habits, including making poor food choices and eating too much.  Habits 
such as overeating, eating rapidly, and hoarding high-calorie foods were reported.  Food 
preoccupation can persist after veterans return home from experiencing food deprivation or 
14 
 
insecurity during deployment.  Interestingly, over 50% of veterans with PTSD and over 21% of 
veterans with no mental health disorder report that stress or depression is their biggest barrier in 
improving their eating habits
7
.   
COPD and Nutrient Needs 
          Malnutrition affects the structure, elasticity, and function of the lungs.  Malnourished 
patients with COPD have a poorer prognosis than nourished patients.  Protein and iron 
deficiencies result in low hemoglobin levels which diminish the oxygen-carrying capacity of the 
blood
21
.   Hypoproteinemia contributes to the development of pulmonary edema, allowing body 
fluids to move into interstitial space.  Low levels of calcium, magnesium, phosphorus, and 
potassium compromise respiratory muscle function at the cellular level
22
.   Normal airway mucus 
is a substance consisting of water, glycoproteins, and electrolytes, and thus requires adequate 
nutritional intake.  Energy requirements are increased since weight loss is common in those with 
COPD.  Weight loss is also associated with a poor prognosis in people with pulmonary disease.  
This disease also affects the absorption and metabolism of most nutrients
19, 23
.    
         Energy expenditure is elevated because of airflow obstruction, thus increasing the energy 
needs from the increased work of breathing. Many different aspects of COPD play a role in 
energy expenditure including gas diffusing capacity, CO2 retention, respiratory inflammation, and 
biochemical mediators, such as hormones and cytokines
4
.   Indirect calorimetry is the “gold 
standard” to determine the correct amount of energy needed for an individual.  Repletion but not 
overfeeding is particularly critical in patients with compromised ability to exchange gases as 
excess feeding of calories result in CO2 that must be expelled.  Fluid, protein, fat and 
carbohydrate needs are determined by the severity of the lung disease, oxygen therapy, 
medications, weight status and fluid fluctuations in COPD patients
4
.  Adequate nutrition is 
15 
 
necessary to maintain or restore lung and muscle strength, as well as to promote immune 
function
19
.   
Nutrients and Lung Function 
          The increased concern of mortality from lung diseases has made maintaining or improving 
lung function a priority.  Many lung diseases involve oxidative stress and inflammation.  
Therefore, nutrients with antioxidant and anti-inflammatory properties may be useful.  These 
nutrients can be observed for prevention or treatment of lung diseases including COPD
2
.
 
  It can 
be beneficial to review nutrient intake and serum levels as they provide pertinent nutritional 
information.   
          Patients with COPD have been shown to have an increase in the level of systemic 
inflammatory markers, suggesting that inflammation is important in exacerbations of COPD.  A 
potential way of reducing lung function decline is looking into reducing the level of circulatory 
inflammatory markers
4
.
  
 In Tsiligianni and Molen’s systematic review, a low intake of vitamins 
C, D, E, A, ɑ-carotene, and ß-carotene, measured by FFQs and serum levels was reported to 
reduce antioxidant defenses and increase the possibility of airway inflammation
24
.   
          Some studies have focused on antioxidants and the presence of lung function and 
respiratory symptoms.  Grievink et al analyzed a sample of 6,555 adults from 1994 to 1995 who 
were given a questionnaire regarding their food consumption and respiratory symptoms.  Vitamin 
C intake was inversely related to cough (OR 0.66; 95% CI 0.50-0.87). It was also found that 
vitamin E intake had no relationship with most symptoms and lung function, but had a positive 
association with productive cough (OR 1.26; 95% CI 1.02-1.56).  ß-carotene was not associated 
with most respiratory symptoms but was positively associated with wheeze (OR 1.27; 95% CI 
1.04-1.55)
9
. 
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           The National Health and Nutrition Examination Surveys (NHANES) have demonstrated 
the positive associations that antioxidant nutrients and anti-inflammatory nutrients have on lung 
function.  NHANES III was conducted throughout the United States with a sample size of 18,162 
adults over the age of seventeen.  Participants were asked to fill out a 24 hour dietary recall and 
their history of smoking or non-smoking.  When nutrients were looked at separately and adjusted 
for caloric intake, vitamin C (9.5 ml FEV1%; 95% CI -0.2 to 19.2), vitamin E (16.4ml FEV1%; 
95% CI 5.5 to 27.4), and total carotene (18.2ml FEV1%; 95% CI 8.7 to 27.6) all were positively 
associated with FEV1% predicted.  The association of each nutrient with FEV1 was found to vary 
somewhat based on smoking status, but these differences were generally not statistically 
significant.  However, for total carotene, the association of dietary intake and FEV1 differed by 
smoking status (p=0.07)
25
.
 
   
 Serum 25-hydroxy vitamin D levels have also showed a positive influence on lung 
function.  Data was collected from NHANES using a cross-sectional survey involving 14,091 
participants who were at least 20 years of age.  All participants who were interviewed, had 
spirometry tests and serum 25(OH) D levels completed. After adjusting for confounders, the 
mean FEV1 and FVC was 126ml and 172ml respectively greater for the highest quintile of serum 
25(OH) vitamin D levels (85.7nmol/L) compared to the lowest quintile (<40.4nmol/L; 
p<0.0001)
26
.  Shaheen et al. found that total vitamin D intake was positively associated with 
FEV1 (p=0.007) and FEV1/FVC (p=0.02) was associated negatively with COPD (OR 0.57; 95% 
CI, 0.38 – 0.87; p=0.02)27.   
 It was also discovered in a cross-sectional study of 414 ex-smokers who had COPD that 
25(OH) D levels were positively associated with FEV1 (p<0.0001).
 
 A greater effect of pack-years 
of smoking on FEV1 decline was significantly different in those with vitamin D deficiency 
(p=0.01)
28
.  In a study involving 626 men from the Normative Aging Study,
 
Lange et al reported 
that the median vitamin D intake was roughly half of the recommended amount according to 
17 
 
other research studies
29
.
 
  This is a concern putting COPD patients at high risk for vitamin D 
deficiency.  Evidence suggests that a significant proportion of COPD patients are vitamin D 
deficient and careful monitoring of this nutrient in this population is recommended
30
.    
 More studies are needed to determine if supplementation of anti-inflammatory nutrients 
would be beneficial.  Black et al. noted a strong relationship between serum concentrations of 
25(OH) D, FEV1, and FVC (p<0.0001) in an analysis using NHANES III data
26
.   Vitamin D is 
thought to protect the body against viral and bacterial infections that can trigger COPD attacks.  
In a meta-analysis of nutritional supplementation, participants with <10ng/ml of 25 (OH) D 
reduced the risk of COPD exacerbations following vitamin D supplementation
25
.
 
 Other studies 
seem to doubt that vitamin D and lung function are correlated.  In the Lung Health Study, there 
were 196 COPD participants which found no relationship between vitamin D levels and rate of 
change in FEV1 (p=0.15)
32
.   Also, an analysis of 973 participants with COPD in a 1-year study 
showed no relation between vitamin D status at baseline and risk of acute exacerbations of COPD 
(p=0.82)
33
.     
          Polyunsaturated fatty acids, specifically omega-3 and omega-6, have been found to play a 
role in lung function.  In the Honolulu Heart Study, men of Japanese descent who smoked 30 or 
less cigarettes per day and ate fish twice or more a week had a 50ml (95% CI 17-87ml) increase 
in their FEV1.  In a cross-sectional analysis using data from The First National Health and 
Nutrition Examination Survey reported that high fish consumption was associated with an ~80ml 
(95% CI: 62, 227) increase in FEV1 in smokers and non-smokers
34
.
 
 J. de Battle et al. discovered 
that a-linolenic acid (omega-3) intake was associated with a significantly lower TNFa serum 
concentration (adjusted OR= 0.46 p=0.049) whereas higher arachidonic acid (omega-6) intake 
was associated with a higher serum concentration of IL-6 (OR=1.96 p=0.034)
3
.  The MORGEN-
EPIC study conducted in the Netherlands involving 13, 820 participants, ages 20 to 59 years, 
discovered something contradicting de Battle’s findings.  Increased intake of docosahexaenoic 
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acid (DHA) was significantly associated with a lower FEV1.  The highest quintile of intake was 
associated with a 39.3ml (95% CI -64.8 to -13.8) lower FEV1 compared with the lowest quintile 
intake.  Higher levels of individual intake of omega-6 fatty acids (i.e. linoleic acid, arachidonic 
acid) were associated with lower FEV1
21
.
   
Omega-6 fatty acids and pro-inflammatory mediators 
are rather complex and not easily predictable.  Some studies suggest that omega-6 fatty acids pro-
inflammatory activities occur only when the intake of omega-3 fatty acids are low.  This may be 
due to omega-3 fatty acids potentially inhibiting arachidonic acid metabolism as ɑ-linolenic acid 
converts into eicosapentaenoic acid (EPA) or DHA
4
.  
 Studies involving vitamin E seem to be inconsistent.  However, the different isoforms of 
this vitamin may explain these conflicting results.  Vitamin E is made up of different isoforms 
including δ, ß, ɑ, and ɣ-tocopherol.  ɑ-tocopherol and ɣ-tocopherol are the most abundantly found 
in the American diet.  There is a 10-fold higher tissue concentration of ɑ-tocopherol when 
compared to ɣ-tocopherol.    Clinical studies indicate that higher intakes of ɑ-tocopherol may 
show a protective effect on adult-asthma and beneficial effect on FEV1 in studies in Finland and 
Italy but not the United States or the Netherlands
35
.
 
   Differences in outcomes from clinical 
reports on the association between vitamin E and asthma may be due to the different intakes and 
serum levels of ɑ-tocopherol and ɣ-tocopherol due to their opposing effects.  In the U.S., diets are 
rich in soy oil which is high in ɣ-tocopherol compared to European diets which are rich in olive 
oil and low in ɣ-tocopherol, which has led some researchers to speculate this may be a partial 
explanation of the high rates of asthma in the United States when compared to other countries
35
. 
 The Coronary Artery Risk Development in Young Adults (CARDIA) study analyzed 
spirometry and serum tocopherol data for over 20 years between white and black adults.  In cross-
sectional regression analysis at year 0, higher serum ɣ-tocopherol was associated with a lower 
FEV1 (p=0.03 in blacks and p=0.01 in all participants) and FVC (p=0.01 in blacks, p=0.05 in 
whites and p=0.01 in all participants).  Whereas higher serum ɑ-tocopherol was associated with 
19 
 
higher FVC (p=0.04 in blacks and whites and p=0.01 in all participants).  In the lowest quartile of 
ɑ-tocopherol serum levels, higher serum ɣ-tocopherol was associated with a lower FEV1 (p=0.05 
in blacks and p=0.02 in all participants).  In contrast, in the lowest quartile of ɣ-tocopherol serum 
levels, higher serum ɑ-tocopherol was associated with a higher FEV1 (p=0.03 in blacks).  Serum 
ɣ-tocopherol >10uM was associated with a 175-545 ml lower FEV1 and FVC at ages 21 to 55 
years.  In the tocopherol isoform quartile analysis, the association of tocopherols with FEV1 were 
most evident when the concentration of the opposing tocopherol was low, causing the least 
competing opposing effect
13
.   
 Similar results were seen in a cohort study involving a random sample of 580 men from 
the Veterans Administration Normative Aging Study.  Men between the ages of 21 and 80 years 
old participated in the study.  This study looked at serum levels of ɑ, ɣ, and δ tocopherol, intake 
of vitamin E and effect of vitamin E supplements, as well as measurements of lung function (i.e. 
FEV1, FVC, and FEV1/FVC).  An inverse association was seen between serum ɣ-tocopherol and 
FEV1 (r= -0.12, p=0.003) and FVC (r= -0.10, p=0.01).  Serum levels of ɑ- and δ-tocopherol were 
not associated with any lung parameters.  After adjusting for confounders, serum ɣ-tocopherol 
maintained a significant inverse association with FVC (B= -0.10, p=0.05)
2
.   This study also 
analyzed the opposing tocopherol actions on lung function.  For this analysis, subjects were 
divided into above or below serum median levels of both ɑ-tocopherol and ɣ-tocopherol.    When 
looking at serum ɣ-tocopherol levels above and below the median, no significant associations 
were found between ɑ-tocopherol and lung function.  However, when analyzing serum ɑ-
tocopherol levels below or above the median, ɣ-tocopherol had a significant inverse relationship 
with lung function measures
2
.  The nutrient intake and supplementation of vitamin E was also 
reviewed in this cohort study.  After adjustment for confounders, vitamin E intake still had a 
positive association with both FEV1 (ß- 0.03, p=0.02) and FVC (ß=0.03, p=0.01).  Vitamin E 
supplementation was associated with an increase in FEV1 (ß= 0.05, p=0.03) and FVC (ß= 0.06, 
p=0.02) after confounders were adjusted.  Supplementation increased ɑ-tocopherol levels 
20 
 
(p<0.0001) and decreased ɣ-tocopherol levels (p<0.0001).  When looking at vitamin E intake 
without supplementation, the relationship between vitamin E intake and lung function was no 
longer significant
2
.
 
 
A summary of nutrients and their antioxidant or anti-inflammatory functions are shown in 
Table 2. 
Table 2: Summary of Nutrients and their Antioxidant and Anti-inflammatory Function 
 Nutrients  Antioxidant/Anti-inflammatory Functions 
Lutein + Zeaxanthin/Lycopene Reduce free radicals
8, 25 
ɑ-carotene 
ß-carotene 
Scavenge oxygen and reduce lipid 
peroxidation
45 
Retinol Shown to protect against respiratory illnesses, 
such as lung cancer.
30, 46 
ß-cryptoxanthin Prevents free radical damage to cells and 
repair damage done.
46 
Vitamin C Maintains antioxidant capacity in the aqueous 
phase of the cell.
46 
Functions as cofactor for enzymes and 
neutralizes free radicals.
46 
Vitamin E Primary defense of cellular membranes 
against oxidative damage.
35 
ɑ-tocopherol Major scavenger of free radicals in the lipid 
phase, such as in the cell membrane. 
Blocks airway hyperactivity.
13,35 
ɣ-tocopherol Pro-inflammatory properties. 
Increases hyperactivity in the lungs.
35 
Vitamin D Regulates expression of genes in bronchial 
smooth muscle cells. 
Deficiency may increase inflammation and 
cause changes to lung function and structure.
30 
Omega-3 Lowers inflammatory markers (i.e. CRP, IL-6, 
and TNFa).
3 
Omega-6 Initiates inflammatory responses in cells.
3 
Zinc Catalytic agent in enzymatic reactions.
25 
Selenium Cofactor for glutathione peroxidase (Important 
antioxidant enzyme).
25 
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Dietary Reference Intakes 
 Dietary reference intakes (DRIs) are a common set of reference values based on 
indicators of nutritional adequacy as well as prevention of chronic disease in healthy populations.  
DRIs are used widely in the United States and include four nutrient-based reference values: 
estimated average requirement (EAR), RDA, adequate intake (AI), and upper limit (UL).  These 
references are used for vitamins, minerals, macronutrients, and energy and were created by the 
Food and Nutrition Board of the Institute of Medicine. 
 The study which included veterans with COPD focused on the use of the RDA and AI for 
antioxidants and anti-inflammatory nutrients.  By definition the RDA is “the average daily dietary 
nutrient intake level that is sufficient to meet the nutrient requirements of nearly all healthy 
individuals in a particular life stage and gender group.”  When an RDA cannot be established due 
to lack of scientific evidence an AI is developed.  It is developed more on judgement and is 
expected to meet or exceed the needs of most healthy individuals and is assumed to be adequate.  
The use of an AI usually indicates that more research is needed to determine the requirements for 
a specific nutrient.   
 The DRIs are not suggested to be used in people with chronic diseases.  Meeting the 
recommended intakes for the nutrients would not necessarily provide enough for individuals who 
are already malnourished, nor would they be adequate for certain disease states marked by 
increase nutrient requirements.  The DRIs are intended to help practitioners arrive at a reasonable 
estimate of the adequate nutrient level required to prevent adverse effects of excess intake.  The 
DRIs, RDA, and AI, were used in this study based on their usage in previous literature
23
. 
Dietary Patterns   
          Looking at overall dietary patterns is becoming more popular in recent research
1
.   Dietary 
patterns focus on a broader representation of dietary intake.  This may be more beneficial than 
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looking at specific nutrients, as dietary patterns may give a better overview of the complicated 
interactions among nutrients.  Dietary patterns can help classify participants as low or high 
antioxidant consumers and help recommend a specific-type diet
35, 36, 37
.   
There are few studies that use the micronutrient adequacy score to look at the quality of a 
diet.  For example, one study looked at a diet score based on the amount of antioxidants in the 
diet of post-menopausal women over the age of 45.  All women had to have a diagnosis of 
osteoporosis to be eligible.  All participants conducted a 3-day food diary.  The antioxidant 
nutrients observed were designated a score of zero or one based on their intake above or below 
2/3
rd
 EAR.  The EAR was used in this study because it is the cut-off recognized by the Institute of 
Medicine.  Majority of participants (90%) were found to have an intake below 2/3
rd
 EAR in 
vitamin E.  However, almost all women had an intake above 2/3
rd
 EAR for zinc and selenium.  It 
was found using ANOVA that there was a significant association between vitamin A and bone 
mass density of the lumbar spine when participant’s vitamin A intake was lower (p=0.013)37.       
 A micronutrient adequacy score was assigned to participant’s nutritional intake using a 
Mediterranean type diet.    Tur, J. et al. used cross-sectional data from 24 hour dietary recalls of a 
sample of 1,200 participants between 16 and 65 years old from the Balearic Islands from 1999 to 
2000.  The dietary questionnaires used were two 24 hour dietary recalls.  The nutrients selenium, 
zinc, ß-carotene, vitamin C, and vitamin E were assigned a score of either zero or one based on 
the criteria below or above 2/3
rd
 recommended dietary intake.  Zinc, ß-carotene, and vitamin E 
were assigned a score of zero.  Selenium and vitamin C intake were >2/3
rd
 RDA and were 
assigned a score of one.  It was also discovered that smoking (OR 1.00; p-value 0.01), a sedentary 
lifestyle (OR 1.79; p-value 0.0001), and having a higher BMI (OR 1.00; p-value 0.0001) 
increased the risk of having a lower antioxidant intake
36
.   
 Another similar study evaluated diet quality using the RDIs.  Aranceta et al. studied 
10,208 participants aged 25 to 60 years old from 1990 to 1998.  Repeated 24 hour dietary recalls 
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were used to assign a diet quality score (DQS) to folate and vitamins A, C, and E.  The score was 
based on the nutrient’s RDI.  More than 35% of the sample was classified as having either a poor 
or very poor DQS.  The poor and very poor DQS were among 47.9% of low educated 
participants, 49.6% of low socio-economic participants, 51.9% of those living in rural areas, and 
49.9% of older adults.  The rate for smokers (49.9%) and obese (88.5%) participants was higher 
than that for non-smokers (41.1%) and non-obese (11.5%) participants.  Overall, dietary patterns 
in people with a good diet score had higher consumption of fruits, vegetables, fish, dairy 
products, eggs, and nuts
38
.   
         A study evaluating the Alternate Healthy Eating Index 2010 investigated the association 
between diet quality and risk of COPD among US men and women.  This Alternative Healthy 
Eating Index includes The Nurses’ Health Study and The Health Professionals Follow-Up Study.  
The Nurses’ Health study included female nurses ages 30 to 55 which began in 1976 and 
involved 73, 228 participants.  The Health Professionals Follow-Up Study began in 1986 
involving 47, 026 men ages 40 to 75 years old.  All participants were mailed a health 
questionnaire.  This questionnaire was sent every two years regarding information on risk factors 
such as smoking habits, weight, and physical activity.  Participants in both studies filled out a 
FFQ at baseline and every two to four years thereafter.  Scoring criteria was based on eleven 
components.  These included vegetables, fruits, whole grains, nuts and legumes, omega-3 fatty 
acids, polyunsaturated fatty acids, alcohol, sugar sweetened drinks and fruit juice, red and 
processed meat, trans fat, and sodium.  Each component was given a minimal score of 0 and a 
maximal score of 10 based on nutrient intake.  The scores were then summed to obtain a total 
score ranging from 0 to 110 with the higher score representing a healthier diet.  After control for 
potential confounders, the risk of newly diagnosed COPD was lower in participants who ate the 
healthiest diet compared to those who ate the least healthy diet HR 0.67 (0.53 to 0.8; p=0.63).  
This inverse association was seen in both ex-smokers HR 0.50 (0.33 to 0.75; p=0.72) and current 
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smokers HR 0.69 (0.49 to 0.98; p= 0.86).  Among both men and women, those with the highest 
score and therefore healthiest diet, were more physically active with 28.4 + 35.7 metabolic 
equivalents per week, less often obese with a mean BMI 24.3kg/m
2
 + 5.0, and less likely to be 
current smokers (4.4% of participants).   The high scores of whole grains and fruits were 
associated with a lower risk of COPD 30% (significant) and 19% (borderline significant) 
respectively.  A low dietary intake of sugar sweetened drinks and fruit juices was associated with 
a 21% lower risk of developing COPD (p for trend 0.02).  A 53% lower risk of diagnosed COPD 
was found with a low intake of red and processed meat (p for trend 0.03).  Vegetables, nuts, trans-
saturated fat, polyunsaturated fatty acids, long chain fats, sodium, and alcohol were found to have 
no significant association with COPD risk
39
.   
Nutrient Supplementation in COPD 
          Vitamin supplementation and COPD outcomes were gathered in a systemic review.  
Vitamins C, E, A, and omega-3 supplementation showed conflicting results.  There is no clear 
evidence of the benefit of supplementation of these antioxidant and anti-inflammatory nutrients.  
Most studies regarding supplementation of a multivitamin showed no benefit in symptoms, 
spirometry function, or hospitalization for COPD
24
.   
 Agacdiken et al researched vitamin E (200IU/day) and vitamin C supplementation 
(500mg/day) in 21 COPD participants and 10 controls for one month.  Supplementation was 
compared to lung function using a treadmill exercise test.  The exercise time of these participants 
increased significantly in those who were supplemented with vitamins E and C (6.4+1.8 vs 
8.8+2.1minutes  p=0.01)
37
.
 
  
 Contrary to these findings, 35 COPD participants were randomly given either a placebo, 
400mg/day of vitamin E, 200mg/day of vitamin E, or 250mg/day of vitamin C for 12 weeks.  
There was no improvement of lung function in the supplemented participants (p>0.05)
38
.
    
Daga et 
al studied 30 COPD participants who were supplemented with 400IU of vitamin E daily for 12 
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weeks.  Between day one and week 12 there was no significance found in FEV1 (p=0.801) or 
FEV1/FVC (p=0.845)
39
.
 
 Vitamin A supplementation has also been researched in lung function.  Vitamin A 
supplementation was provided for 30 days to participants who had and did not have COPD 
including those who smoked and did not smoke.  The mean FEV1 increased by 22.9% in the 
COPD vitamin A supplemented group (p=0.004)
40
.     
 Research on fish oil supplementation and lung function is limited.  Shahar et al noted that 
COPD was strongly and inversely related to the intake of omega-3 through fish consumption in a 
dose-response fashion (p<0.001).  This means that a higher intake of omega-3 decreases the risk 
of COPD
44
.
  
  Schwartz et al mentioned that supplementation of omega-3 fatty acids much higher 
than average dietary intake may have health benefits
34
.
    
 
 A small study used fish oil supplementation to see its effects on neutrophils and 
monocytes.  A group of seven men ages 22 to 53 years were provided supplementation.  The 
supplement provided 3.2g of EPA, and 2.2g of DHA.  Blood was withdrawn before 
supplementation, after three weeks, and after six weeks of supplementation.  It was concluded 
that dietary supplementation of fish oil for six weeks resulted in the impairment of leukotriene 
B4.  This may stimulate mucus secretions in the airways of the lungs
42
.
  
 This demonstrates that 
fish oil supplementation perhaps decreases the mucus in the lungs allowing COPD patients to be 
able to breathe better.   
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PARTICIPANTS AND METHODS 
Participants and Study Design 
 This study was a secondary analysis of patients enrolled in the AgCOPD study, a larger 
study of COPD patients and controls, agricultural exposure, and genotype conducted through the 
Veterans Affairs (VA) Medical Center.  After approval was obtained through the VA Institutional 
Review Board, the AgCOPD database was used to identify participants with COPD, as defined by 
an FEV1/FVC ratio of less than 70%.  Exclusion criteria included participants without a diagnosis 
of COPD or anyone who did not fill out a FFQ.      
Data Collection 
 The Harvard FFQ was used to gather the nutritional data, including the absolute values of 
nutrient intakes via food and supplementation.  FFQs were mailed out to 168 participants with 
COPD to obtain their nutritional intake.  Forty-two FFQs were returned and then sent to Harvard 
for analysis.  Anthropometric data were gathered from the participant’s VA records collected as 
part of the larger study.  Demographic information was also collected for all participants 
including age, gender, and race.  According to the American Thoracic Society, post 
bronchodilator lung function is what is used to diagnose COPD
44
.   Post-bronchodilator FEV1, 
FVC, and FEV1/FVC was used to determined lung function.  Smoking status was also collected 
and categorized as current, former, or never.  Vitamins A, C, D, and E, zinc, ß-carotene, omega-3, 
and lycopene were also analyzed to see if supplementation of these nutrients did or did not 
improve lung function. 
 Fifteen specific nutrients were chosen for inclusion in the analysis based on their 
antioxidant or anti-inflammatory properties that have previously been associated with lung 
disease in the literature. Lutein + zeaxanthin and lycopene reduce free radicals, whereas ɑ-
carotene and ß- carotene deficiency in fetuses can cause malformation of the lungs, and 
functional defects in adults
8,25,45
.   Retinol has been shown to protect against respiratory illnesses, 
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such as lung cancer and ß-cryptoxanthin prevents free radical damage to cells and helps repair 
damage done
30, 46
.
 
  Vitamin C helps maintain antioxidant capacity in the aqueous phase of the cell 
and also functions as a cofactor for enzymes and neutralizes free radicals
46
.
   
 Other nutrients evaluated include vitamin E, vitamin D, omega 3 and omega 6, zinc and 
selenium.  Vitamin E is the primary defense of cellular membranes against oxidative damage and 
it has been associated with lung disease in the literature.  Vitamin E consists of four natural 
isoforms which consist of ɑ, ß, ɣ, and δ tocopherol. ɑ-tocopherol and ɣ-tocopherol are the most 
abundant in the diet and tissues and have been associated with lung function in the literature
35
.  ɑ-
tocopherol has been studied the most which blocks airway hyperactivity whereas ɣ-tocopherol is 
pro-inflammatory and increases hyperactivity
13, 35
.  Vitamin D regulates expression of genes in 
bronchial smooth muscle cells and deficiency may increase inflammation and cause changes to 
lung function and structure
30
.
 
  Like Vitamin D, omega-3 fatty acids are anti-inflammatory and 
lowers inflammatory markers such as CRP, IL-6, and TNFa.  Omega-6 has the opposing affect 
and initiates inflammatory responses in cells
3
.   Zinc is a catalytic agent in enzymatic reactions 
and selenium is a cofactor for glutathione peroxidase, which is an important antioxidant 
enzyme
25
.   
A micronutrient adequacy score was created using the individual nutrient intake of each 
participant.  This score included the consumption of RAEs, vitamin C, vitamin D, ɑ-tocopherol, 
sodium, selenium, and zinc.  A score of 0 was given if the participant’s specific nutrient intake 
was <2/3
rd
 the RDA.  A score of 1 was assigned if the participant’s individual nutrient intake was 
> 2/3
rd
 the RDA.  A total score was assigned to each participant and could range from 0-7 with 7 
being considered the diet with the highest amount of antioxidant and anti-inflammatory nutrients.  
According to the Food and Nutrition Board of the Institute of Medicine, the RDA is the daily 
level of intake sufficient to meet the nutrient requirements of nearly all healthy people.  The 
fraction 2/3
rd
 RDA was chosen based on its previous use in studies using an adequacy score
36, 38
.  
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All data was obtained from an investigator familiar with VA participants or a trained 
dietitian.  This data was all compiled in an excel spreadsheet and patient identifiers were not 
recorded.  All available information on each participant was included in the analysis.   
Data Analysis 
 Descriptive statistics were calculated for all variables and continuous data are represented 
as mean and standard deviation.  The mean and standard deviation were calculated for age and 
lung function (i.e. FEV1, FVC, and FEV1/FVC).  Categorical data are expressed as counts and 
percentages which were used for gender, BMI, race, smoking status, and GOLD stages.    
 The mean intake and proportion of participants who met either 2/3
rd 
RDA or RDA was 
calculated for each nutrient.  Nutrients that are assigned an AI or non-established DRI also had 
mean intake and proportion of 2/3
rd
 AI or AI met calculated.  Since the data was normally 
distributed mean was used to determine the average of each nutrient.  Determining the proportion 
of 2/3
rd
 RDA or 2/3
rd
 AI met for each nutrient helped create the micronutrient adequacy score.  
The purpose of this study is to determine if there is an association between intakes of 
antioxidants and anti-inflammatory nutrients with lung function in veterans with COPD.  
Spearman’s correlation coefficient was calculated to determine if there is an association between 
nutrient intake and lung function.  Spearman’s correlation coefficient was also used to determine 
the association between the micronutrient adequacy score and lung function.  Variables 
significant in the univariate analysis were included in a multivariate regression model that 
adjusted for the possible confounders of age and smoking.  A decision was made to dichotomize 
the micronutrient adequacy score using the median of 4.  Comparisons using the dichotomized 
micronutrient adequate score and median lung function were made using a Mann-Whitney test.  
Median nutrient intakes were compared between smoking statuses using a Kruskal-Wallis test.  
Median lung function and median nutrient intake were gathered in these last two statistical tests 
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due to the non-normally distributed data.   
 The median micronutrient adequacy score was also compared to COPD stage 1 vs. stages 
2-4 to see if those who had worse COPD had a lower median micronutrient score.   Although 
COPD has four stages, a decision was made to divide the four stages into two groups based on the 
distribution of the data.  A Mann-Whitney test was performed due to the small sample size of 
each individual group and normality could not be assumed.  This test was also used when looking 
at median lung function compared to those who used supplements versus those who did not.  
Supplementation was represented categorically (Y/N).    All statistical analysis was performed 
using SPSS and adjustments for confounders included age and smoking.  Statistical significance 
was set at a p-value < 0.05.    
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RESULTS 
A summary of the descriptive statistics can be seen in Table 3.  Among the 42 
participants 41 (98%) were males with the mean age of 66.4 + 7.8 years.  All participants were 
white with a mean BMI of 29.3kg/m
2
 + 7.5.  The lowest BMI was 16.5kg/m
2 
with the highest 
BMI being 58.9kg/m
2
.  The mean lung function data was also collected.  Mean FEV1 was 2.4L + 
0.9, mean FVC was 4.1L + 1.0, and mean FEV1/FVC was 0.6L + 0.1.   
Table 3: Descriptive Statistics for Participants with COPD 
 N Mean (SD) 
Age (years) 42  66.4 (7.8) 
Lung Function (L)   
FEV1 35  2.4 (0.9) 
FVC 35  4.1 (1.0) 
FEV1/FVC 35  0.6 (0.1) 
 N % (Percentage) 
Gender   
Male 41   98 
Female 1     2 
BMI (kg/m
2
)   
18.5-24.0 9    21 
25.0-29.9 18  43 
30.0-34.9 9    21 
35.0-39.9 2    5 
>40 4    10 
Race   
White 42   100 
African American 0      
Native American 0      
Asian 0      
Other 0      
Smoking Status 
Current/Former/Never 
7 /29 /6 17/29/14 
COPD GOLD Stages 
1, 2, 3/4  
11/ 16/ 8 26/38/19 
 
The mean intake of each nutrient observed can be seen in Tables 4, 5, and 6.  The 
proportion of participants whose intake was above 2/3
rd
 RDA/AI and RDA/AI is included in 
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Tables 4 and 5.  Seventy-nine percent met 2/3
rd
 of the RDA for RAEs and vitamin C.  Twenty-
one percent of participants met 2/3
rd
 of the AI for omega-3 and over half (55%) met 2/3
rd
 the AI 
for omega-6.  None of the participants met either 2/3
rd
 the RDA or the RDA for selenium, 
however all 42 participants met 2/3
rd
 of the AI for sodium.  Participants also consumed more of 
the pro-inflammatory nutrient ɣ-tocopherol (11mg) than the anti-inflammatory nutrient of ɑ-
tocopherol (8mg).  Regarding the micronutrient adequacy score, 30 participants (71%) had a 
score of 4 or greater which showed a higher intake of antioxidants and anti-inflammatory 
nutrients (Table 6).  However, when the nutrient consumption was evaluated separately, a low 
percentage of participants met the RDA or AI for vitamin D, ɑ-tocopherol, omega-3, omega-6, 
zinc, and selenium.   
Table 4: Mean Intake and Proportion of Participants who met 2/3 RDA and RDA 
Nutrient Mean Intake Recommended 
Dietary 
Allowance 
(RDA) 
Percent who 
met  
2/3 RDA 
Percent who 
met  
RDA 
RAE (ug)* 1400 900ug men 
700ug women 
79 
2 
74 
2 
Vitamin C (mg) 166 90mg men 
70mg women 
79 
2 
67 
2 
Vitamin D (mg) 11 20mg 26 19 
ɑ-tocopherol (mg)** 8 15mg 14 5 
Zinc (mg) 16 11mg men 
8mg women 
34 
2 
25 
0 
Selenium (ug) 2.9 55ug 0 0 
 
*Vitamin A RDA is based on RAEs which consists of retinol, ß-carotene, ɑ-carotene, and ß-
cryptoxanthin 
**Vitamin E RDA is based on ɑ-tocopherol 
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Table 5: Mean Intake and Proportion of Participants who met 2/3 AI  
Nutrient Mean Intake Adequate 
Intake (AI) 
Percent who 
met 2/3 AI 
Percent who 
met AI 
Omega-3 (g)*** 0.3 1.6g men 
   1.1g women 
21 
0 
21 
0 
Omega-6 (g)*** 14 14g men 
 8g women 
55 
2 
16 
0 
Sodium (mg)*** 2199 1200mg 100 90 
 
***AI used because not enough scientific evidence to determine an EAR and therefore an RDA 
Table 6: Mean Intake of Nutrients with a Non-established DRI 
Nutrient Mean Intake 
Retinol (ug) 842 
ɑ-carotene (ug) 721 
ß-carotene (ug) 3987 
ß-cryptoxanthin (ug) 133 
Lutein+Zeaxanthin (ug) 2195 
Lycopene (ug) 4634 
ɣ-tocopherol (mg) 11 
Micronutrient 
Adequacy Score 
4 
 
Spearman’s correlation coefficient revealed four significant relationships between 
nutrient intake and lung function.  Omega-3 was found to have an inverse relationship with FEV1 
(r= -0.357, p= 0.03) and FEV1/FVC (r= -0.336, p=0.048).  ɣ-tocopherol (r= -0.336 and p= 0.048) 
and omega-6 (r= -0.422 and p= 0.012) had an inverse relationship with FEV1/FVC as well.   All 
correlations can be found in Table 7 and significant findings were depicted using scatterplots 
(Figures 1-4).  No significant relationships were discovered between nutrient intake and FVC.  
The four significant relationships between nutrient intake and lung function were adjusted for 
confounders.  Due to the small sample size our adjustments were limited to age and smoking.  
The results of these adjustments can be seen in Table 7.  The relationship between omega-3, 
omega-6, and ɣ-tocopherol with lung function were no longer significant after adjusting for 
confounders.  
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Table 7: Results of correlation and regression models for the relationship between nutrient intake and lung function (adjusted for age and 
smoking)intake and lung function (adjusted for age and smoking) 
 
 
 
 
 
 Univariate Analysis Multivariate Analysis 
 FEV1 FVC FEV1/FVC FEV1 FVC FEV1/FVC 
Nutrient r p r p r p ß p ß p ß p 
Vitamin C  0.196 0.259 0.260 0.131 0.132 0.450       
Vitamin D 0.138 0.428 0.181 0.298 0.073 0.676       
Retinol -0.027 0.876 -0.006 0.973 -0.020 0.908       
ɑ-carotene -0.152 0.348 0.066 0.705 -0.223 0.197       
ß-carotene -0.13 0.455 0.007 0.966 -0.090 0.607       
ɑ-tocopherol 0.054 0.756 0.276 0.109 -0.128 0.465       
δ-tocopherol -0.032 0.833 0.238 0.168 -0.294 0.087       
ɣ-tocopherol -0.128 0.465 0.189 0.276 -0.336 0.048     -0.147 0.40 
Omega-3 -0.357 0.035 -0.046 0.791 -0.430 0.010 -0.21 0.22   -0.27 0.11 
Omega-6 -0.236 0.172 0.090 0.608 -0.422 0.012     -0.263 0.12 
Zinc -0.013 0.940 0.003 0.985 0.050 0.774       
Selenium -0.037 0.833 -0.014 0.937 0.085 0.629       
Sodium 0.054 0.757 0.145 0.407 -0.125 0.473       
ß-
cryptoxanthin 
0.067 0.701 0.102 0.560 0.021 0.906       
Lutein + 
Zeaxanthin 
-0.046 0.795 0.078 0.656 -0.017 0.924       
Lycopene 0.047 0.790 -0.012 0.946 0.140 0.423       
34 
 
 
Figure 1: Association between Omega-3 and FEV1 
 
Figure 1:  There was a negative relationship between Omega-3 intake and FEV1  (r= -0.357, p= 
0.04) 
 
Figure 2: Association between Omega-3 and FEV1/FVC 
 
Figure 2:  There was a negative association between Omega-3 intake and FEV1/FVC (r= -0.43, 
p=0.01) 
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Figure 3: Association between ɣ-tocopherol and FEV1/FVC 
 
Figure 3:  There was a negative association between ɣ-tocopherol intake and FEV1/FVC  
(r=0.34,p=0.05) 
Figure 4: Association between Omega-6 and FEV1/FVC 
 
Figure 4:  There was a negative relationship between Omega-6 intake and FEV1/FVC 
(r= -0.42, p=0.01) 
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 The Spearman correlation coefficient showed no significant relationship between the 
micronutrient adequacy score and FEV1, FVC, and FEV1/FVC.  No significant associations were 
found when the micronutrient adequacy score was dichotomized and compared to the median 
lung function using a Mann-Whitney test.  A summary of the data is described in Tables 8 and 9.  
The median micronutrient adequacy score was also compared between COPD stages.  Due to the 
distribution, the COPD stages were dichotomized and a Mann-Whitney test was performed to 
determine if participants with worse COPD would have a lower micronutrient adequacy score 
(Data not shown, p-value 0.828).   
Table 8: Micronutrient Adequacy Score compared to Lung Function 
 FEV1 FVC FEV1/FVC 
 Spearman’s 
Correlation 
P-value Spearman’s 
Correlation 
P-value Spearman’s 
Correlation 
P-value 
Micronutrient 
Adequacy 
Score 
0.092 0.599 0.121 0.488 0.100 0.567 
 
Table 9: Dichotomize Micronutrient Adequacy Score compared to Lung Function 
Micronutrient 
Adequacy Score 
Number of 
Participants 
FEV1 
Median (Min, 
Max) 
FVC 
Median (Min, 
Max) 
FEV1/FVC 
Median (Min, 
Max) 
<4 (n=0) 11 2.29 (1.43, 3.20) 4.37 (3.18, 5.63) 0.59 (0.43, 0.69) 
>4 (n=1) 24 2.27 (0.67, 4.78) 4.00 (1.98, 6.63) 0.60 (0.34, 0.72) 
P-value - 0.756 0.841 0.971 
 
There was no significance between smoking status and the median nutrient intake using a 
Kruskal-Wallis test depicted in Table 10.   
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Table 10: Median Nutrient Intake among Current, Former, and Never Smokers 
Nutrient Smoking Status p-value 
 Current  
Median (Min, 
Max) 
Former  
Median (Min, 
Max) 
Never  
Median (Min, 
Max) 
 
Vitamin C 86 (15, 318) 118 (31, 730) 143 (48, 1270) 0.549 
Vitamin D 295 (67, 1445) 335 (39, 1663) 282 (66, 906) 0.351 
Retinol 2303 (605, 5879) 2396 (357, 
9918) 
1645 (474, 4747) 0.483 
ɑ-carotene 434 (264, 858) 368 (0, 3620) 492 (88, 1319) 0.895 
ß-carotene 3223 (1267, 16278) 2312 (2, 13408) 4288 (1860, 
6365) 
0.588 
ɑ-tocopherol 6 (3, 13) 7 (3, 27) 6 (3, 11) 0.451 
ɣ-tocopherol 10 (6,16) 10 (4, 45) 7 (5, 12) 0.106 
d-tocopherol 2 (1, 3) 2 (1, 5) 2 (1, 3) 0.282 
Omega-3 0.3 (0.0, 1) 0.1 (0, 1) 0.2 (0, 0.4) 0.369 
Omega-6 13 (8, 24) 12 (5, 73) 10 (6, 27) 0.205 
Zinc 11 (6, 22) 14 (5, 74) 13 (6, 27) 0.798 
Selenium 0 (0, 10) 0 (0, 20) 0 (0, 20) 0.528 
Sodium 1921 (1028, 3070) 2046 (1028, 
5452) 
2244 (1197, 
3478) 
0.871 
ß-cryptoxanthin 69 (5, 193) 116 (0, 519) 163 (22, 215) 0.939 
Lutein + 
Zeaxanthin 
1384 (833, 3545) 1763 (8, 11435) 2377 (1768, 
4055) 
0.293 
Lycopene 5787 (1840, 21769) 2709 (0, 16880) 3811 (0, 10030) 0.201 
 
 A Mann-Whitney test was used when looking at median lung function compared to those 
who used supplements versus those who did not.  Supplementation of vitamins A, C, D, and E, 
Zinc, Fish Oil (Omega-3), ß-carotene, and lycopene were included, but no statistical significance 
was found (Tables 11-13).    
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Table 11: Supplementation of Nutrients and FEV1   
Supplement FEV1  
Median (Min, Max) 
p-value 
Vitamin A   
NO (n=23) 2.32 (0.67, 3.89) 0.831 
YES (n=19) 2.15 (1.05, 4.78)  
   
Vitamin C   
NO (n=23) 2.32 (0.67, 3.89) 0.616 
YES (n=19) 2.15 (1.05, 4.78)  
   
Vitamin E   
NO (n=25) 2.27 (0.67, 3.43) 0.934 
YES (n=17) 2.26 (1.05, 4.78)  
   
Vitamin D   
NO (n=24) 2.47 (1.12, 3.43) 0.756 
YES (n=18) 2.15 (0.67, 4.78)  
   
Zinc   
NO (n=14) 2.39 (0.67, 3.89) 0.687 
YES (n=28) 2.10 (1.05, 4.78)  
   
ß-carotene   
NO (n=19) 2.32 (0.67, 3.89) 0.831 
YES (n=23) 2.15 (1.05, 4.78)  
   
Omega-3   
NO (n=10) 2.42 (0.67, 4.78) 0.093 
YES (n=32) 1.91 (1.05, 2.7)  
   
Lycopene   
NO (n=13) 2.32 (0.67, 4.78) 0.725 
YES (n=29) 2.15 (1.05, 3.20)  
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Table 12: Supplementation of Nutrients and FVC 
Supplement FVC  
 Median (Min, Max) 
p-value 
Vitamin A   
NO (n=23) 3.89 (1.98, 5.88) 0.564 
YES (n=19) 4.13 (2.2, 6.63)  
   
Vitamin C   
NO (n=23) 3.89 (1.98, 5.88) 0.769 
YES (n=19) 4.13 (2.2, 6.63)  
   
Vitamin E   
NO (n=25) 3.77 (1.98, 4.90) 0.364 
YES (n=17) 4.08 (2.2, 6.63)  
   
Vitamin D   
NO (n=24) 3.89 (2.84, 4.90) 0.589 
YES (n=18) 4.13 (1.98, 6.63)  
   
Zinc   
NO (n=14) 4.10 (1.98, 6.63) 0.494 
YES (n=28) 4.03 (2.2, 4.93)  
   
ß-carotene   
NO (n=19) 3.89 (1.98, 5.89) 0.564 
YES (n=23) 4.13 (2.2, 6.63)  
   
Omega-3   
NO (n=10) 4.13 (1.98, 6.63) 0.334 
YES (n=32) 3.80 (2.27, 4.72)  
   
Lycopene   
NO (n=13) 3.83 (1.98, 5.89) 0.342 
YES (n=29) 4.30 (2.2, 6.63)  
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Table 13: Supplementation of Nutrients and FEV1/FVC 
Supplement FEV1/FVC  
Median (Min, Max) 
p-value 
Vitamin A   
NO (n=23) 0.61 (0.34, 0.72) 0.681 
YES (n=19) 0.58 (0.43, 0.72)  
   
Vitamin C   
NO (n=23) 0.61 (0.34, 0.72) 0.616 
YES (n=19) 0.58 (0.43, 0.72)  
   
Vitamin E   
NO (n=25) 0.60 (0.34, 0.72) 0.987 
YES (n=17) 0.60 (0.43, 0.72)  
   
Vitamin D   
NO (n=24) 0.61 (0.34, 0.72) 0.567 
YES (n=18) 0.58 (0.34, 0.72)  
   
Zinc   
NO (n=14) 0.61 (0.34, 0.72) 0.740 
YES (n=28) 0.58 (0.45, 0.72)  
   
ß-carotene   
NO (n=19) 0.61 (0.34, 0.72) 0.681 
YES (n=23) 0.58 (0.43, 0.72)  
   
Omega-3   
NO (n=10) 0.61 (0.34, 0.72) 0.292 
YES (n=32) 0.46 (0.45, 0.68)  
   
Lycopene   
NO (n=13) 0.59 (0.34, 0.72) 0.897 
YES (n=29) 0.64 (0.43, 0.72)  
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DISCUSSION 
 
Nutrient Intake and DRI 
 The nutrient intake of antioxidants and anti-inflammatory nutrients was analyzed in this 
study with participants from the VA.  Seventy-nine percent of participants met 2/3
rd
 RDA for 
RAEs and vitamin C as seen in Table 4.  This is likely due to the American diet being abundant in 
vitamins A and C
47, 48
.
 
  The mean omega-3 intake (0.3g) was very low considering the AI is 
between 1.1 to 1.6g depending on gender.  Only 21% of participants met 2/3
rd
 AI and AI for this 
nutrient.  This may explain why a significant negative association was found between omega-3 
with FEV1 and FEV1/FVC before adjusting for confounders.  The mean intake of omega-6 was 
14g which is the AI for this nutrient.  Over half (55%) of participants met 2/3
rd
 AI of omega-6 
which was found to have a significant negative association with lung function before adjusting for 
confounders.  The mean intake of selenium was below the RDA, and no participants even met the 
nutrient’s 2/3rd RDA.  This may have affected lung function in a negative way as selenium is an 
antioxidant.  Participants consumed more of the pro-inflammatory nutrient ɣ-tocopherol (mean 
intake of 11mg) than the anti-inflammatory nutrient of ɑ-tocopherol (mean intake of 8mg).  Only 
14% met 2/3
rd
 RDA for ɑ-tocopherol meaning that participants had a much lower intake of this 
anti-inflammatory nutrient.       
Nutrient Intake and Lung Function 
 Four significant relationships between nutrient intake and lung function were found in 
this study prior to adjusting for confounders.  Omega-3 was found to have an inverse relationship 
with FEV1 and FEV1/FVC before adjusting for age and smoking.  This was unexpected as omega-
3 has anti-inflammatory properties and has been found in the literature to increase these lung 
function values
3, 34
.   In the Honolulu Heart Study, men that ate fish at least twice a week had a 
50ml increase in their FEV1.  High fish consumption contributed to approximately 80ml increase 
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in FEV1 in the first NHANES study
34
.   Whereas the Morgen-Epic study discovered an increase 
intake of DHA was significantly associated with a lower FEV1
9
.  The inverse relationship found 
prior to adjusting for confounders in the COPD study involving participants from the VA was 
likely due to the poor intake of this nutrient, as only 21% met 2/3
rd
 AI.  Veterans in this study had 
a mean omega-3 intake of 0.3g which is way below the AI of 1.6g for men.  Food items 
containing omega-3 in the FFQ included fish, walnuts, flaxseed, and canola and soybean oil.  
Based on these results, veterans should be encouraged to eat more omega-3 dense foods such as 
those listed on the FFQ.  Before adjusting for confounders, omega-6 was observed to have a 
significant inverse relationship with FEV1/FVC which was expected due to its pro-inflammatory 
properties.  Previous research studies have also found similar results of an inverse relationship
3, 21
.   
The Morgen-Epic study found that higher levels of individual intake of omega-6 fatty acids (i.e. 
linoleic acid, arachidonic acid) were associated with a lower FEV1
21
.
   
Also, over half of the 
participants were found to have met 2/3
rd
 AI of omega-6.  Some studies suggest that omega-6 
fatty acids’ pro-inflammatory activities occur only when the intake of omega-3 fatty acids are 
low
3
.
  
  This may also explain why omega-6 had an inverse relationship before adjusting for age 
and smoking, since more participants met 2/3
rd
 AI for omega-6 than for omega-3.   
 Before adjusting for confounders, ɣ-tocopherol was also found to have a significant 
inverse relationship with FEV1/FVC.  More participants consumed this pro-inflammatory nutrient 
than ɑ-tocopherol, which has been found to improve lung function13, 35.   This result was predicted 
based on previous research studies.  It is also not surprising that participants had a higher intake 
of ɣ-tocopherol as the United States has a high consumption of soy oil, which is high in this pro-
inflammatory nutrient
35
.  In the Coronary Artery Risk Development in Young Adults study, 
higher serum ɣ-tocopherol was associated with a lower FEV1 and FVC
13
.
   
Hanson et al. also 
found a significant inverse relationship between serum ɣ-tocopherol and FVC after adjusting for 
confounders (B= -0.10, p=0.05)
2
.
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 Possible confounders for this study would be age, height, weight, BMI, smoking, vitamin 
supplementation, and caloric intake.  Based on the small sample size, age and smoking were 
selected to be adjusted for confounders.  After omega-3 was adjusted for age and smoking, no 
significant relationship was found between FEV1 and FEV1/FVC.  After adjusting for 
confounders, omega-3 would have been expected to have a positive association with lung 
function based on previous literature.  However, the very poor intake of this nutrient may explain 
why a positive relationship was not found.  No relationship was found between ɣ-tocopherol and 
omega-6 with FEV1/FVC after adjusting for confounders.  This was unexpected as current 
literature explains that these nutrients have a negative association with lung function.  Also, the 
nutrient intake of ɣ-tocopherol and omega-6 were higher than anti-inflammatory nutrients that 
were analyzed.   
 Based on previous studies, there is a relationship between nutrient intake of antioxidants 
and anti-inflammatory nutrients with lung function.  This VA study likely did not find a 
significant relationship between nutrient intake and lung function due to the small sample size 
and very poor nutrient intake of the participants.  For instance, the Healthy Eating Index 2010 
found a significant relationship between nutrient intake and lung function after adjusting for 
confounders.  This is likely due to the large sample size and better consumption of antioxidant 
and anti-inflammatory nutrients.   
Micronutrient Adequacy Score 
 No significant relationships between the micronutrient adequacy score and lung function 
were found.  Even when the COPD stages were dichotomized to above or below the median 
micronutrient adequacy score, no significant associations were found between lung function.  A 
small sample size and low nutrient intakes are likely the causes of these findings.  Based on the 
results of the VA study, it is unable to conclude that having a diet higher in antioxidants and anti-
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inflammatory nutrients will decrease the risk of having COPD.  An association may have been 
found with a larger sample size and higher consumption of antioxidant and anti-inflammatory 
nutrients.  In the study evaluating the Alternative Healthy Eating Index 2010, the risk of newly 
diagnosed COPD was lower in participants who ate the healthiest diet compared to those who ate 
the least healthy diet
39
.
   
This study involving the Alternative Healthy Eating Index 2010 also used 
FFQs to gather data, however it involved more participants and was conducted over a longer 
period of time.  It was also discovered that those who have a higher score, and therefore healthier 
diet, tend to be non-smokers and non-obese
38, 39
.   
Nutrient Intake and Smoking Status 
 There was no significance found between median nutrient intake and smoking status 
using a Kruskal-Wallis test.  There were more former (n=29) and current (n=7) smokers 
compared to never (n=6) smokers.  Perhaps if there was a larger sample size and normal 
distribution among the three smoking status groups a significance between median nutrient intake 
and smoking status may have been found. 
Nutrient Supplementation and Lung Function 
 No significant findings were found between median FEV1, FVC, and FEV1/FVC with 
those who did and did not use supplementation of vitamins A, C, D, and E, zinc, omega-3, ß-
carotene, and lycopene.  Previous research observing supplementation is limited and some 
findings are contradictory.  In a previous study, vitamin A supplementation was provided to 
COPD participants for 30 days.  The mean FEV1 increased by 22.9% in those who took a vitamin 
A supplement
41
.
 
  In a study looking at the impact of vitamins E and C supplementation on 
exercise, those that used supplementation had a significant increase in their exercise time
49
.
  
  
However, vitamins E and C supplementation was found to not improve lung function in two 
studies involving COPD participants
40, 50
.
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 Schwartz et al. noticed that supplementation of omega-3 fatty acids in high dosages may 
have some health benefits
34
. 
 
Supplementation of fish oil for 6 weeks also was shown to decrease 
mucus in lungs, allowing COPD participants better ability to breathe.  Omega-3’s poor nutrient 
intake or perhaps the supplementation dosages of omega-3 were not high enough in the VA study 
to make a difference.  Currently the scientific evidence to set an appropriate range for 
supplementation of certain antioxidants or anti-inflammatory nutrients is unclear.  Since vitamins 
A, C, D, and E, zinc, omega-3, ß-carotene, and lycopene all have antioxidant and anti-
inflammatory affects, it was predicted that supplementing these nutrients would improve lung 
function.  The research on these nutrients and supplementation to improve lung function is 
contradictory and unclear at this point.   
Limitations 
 There are several limitations to this research study.  First, seven of the forty-two 
participants did not have spirometry test results available.  However, all 42 participants filled out 
a FFQ.  The nutrient intakes of these participants with and without lung function are valuable.  
Therefore, all 42 participants were included in this study.  FFQs at best reflect a short-term intake 
which can vary day-to-day.  It is hard to measure dietary intake accurately even with detailed 
questionnaires regarding food portions
25
.
 
   
 Sample size may also be a source of bias as a larger sample size may have strengthened 
associations.  Gender differences were also a limitation as only one female participated in this 
study.   The DRIs are also not suggested to be used in people with chronic diseases such as 
COPD.  The recommended intakes for the nutrients would not necessarily provide enough 
nutrition for individuals who are already malnourished, nor would they be adequate for certain 
disease states marked by increase nutrient requirements.   
 Serum levels were not included in this study but they are more likely to reflect long-term 
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nutrient status and nutrient bioavailability
25
.
  
 Supplementation used as a categorical variable is 
another limitation to this study.  It would have been useful to compare dosages of the 
supplementation used since there were no significant findings between supplementation and lung 
function.   
Strengths 
 A strength of this study was focusing on lung function specifically in participants with 
COPD.  Research regarding nutrient intake and COPD is currently conflicting and more evidence 
is needed in this area.  This research study can contribute to helping people delay or treat this 
disease by making veterans aware of nutritional deficiencies and their potential negative impacts.   
Also, using the Harvard FFQ for analysis provides more accurate information on nutrient intake 
compared to dietary records or recalls.   
Applications for Clinical Practice  
 Interest in this study developed due to the lack of medical nutrition therapy emphasis in 
lung diseases.  In the VA study, no significant association was found between antioxidant and 
anti-inflammatory nutrients with lung function after adjusting for confounders.  However, 
participants were low in vitamin D, ɑ-tocopherol, omega-3, and selenium which could have 
negatively impacted the results of the study.  A median micronutrient adequacy score of 4 and a 
poor dietary pattern was found in the VA study.  Knowing that many of the participants had a low 
intake of these important nutrients is a starting point for a dietitian.  Increasing the intake of these 
antioxidants and anti-inflammatory nutrients should be a priority in this patient population.    A 
registered dietitian would be able to improve the nutrient intake by dietary modifications and 
lifestyle changes.   
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CONCLUSION 
  
 After adjusting significant findings for confounders, it cannot be concluded that there is 
an association between antioxidant and anti-inflammatory nutrients.  From the review of the 
literature, a majority of these nutrients have a positive association with lung function.   However, 
there are conflicting results in the literature and more research is needed in this area.   
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